raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:521406

Dystonia-parkinsonism-hypermanganesemia syndrome

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy
Status
active

A rare disorder of manganese transport characterized by progressive movement disorder and elevated blood manganese levels. Patients present in infancy or early childhood with loss of motor milestones, rapidly progressive dystonia, spasticity, bulbar dysfunction, and parkinsonism, resulting in loss of independent ambulation. Cognition may be impaired but is generally better preserved than motor function. Additional manifestations include abnormal head growth and skull deformities. Brain MRI shows abnormalities of the basal ganglia, variably also of other brain regions.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDystonia-parkinsonism-hypermanganesemia syndrome
frSyndrome de dystonie-parkinsonisme-hypermanganésémie
deDystonie-Parkinsonismus-Hypermanganämie-Syndrom
esSíndrome de distonía-parkinsonismo-hipermanganesemia
itSindrome distonia - parkinsonismo - ipermanganesemia
nlDystonie - parkinsonisme - hypermanganesemie-syndroom
ptSíndrome de distonia-parkinsonismo-hipermanganesémia
plZespół dystonii-choroby Parkinsona-hipermagnezemii
csSyndrom zahrnující dystonii, parkinsonismus a hypermanganémii
ukСиндром дистонії-паркінсонізму-гіпермарганцемії
zh肌张力障碍-帕金森症-高锰血症综合征
trDistoni-parkinsonizm-hipermanganezemi sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM617013Evalidated
ICD-10E83.8NTBTattributedvalidated
MONDO0014864Evalidated
UMLSC4310765Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
SLC39A14Disease-causing germline mutation(s) inAssessedHGNC:20858ENSG000001046356087368p21.3solute carrier family 39 member 1429382362[PMID]_29685658[PMID]_27231142[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families11 casesWorldwideCase(s)Validated29382362[PMID]_29685658[PMID]_27231142[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_29382362[PMID]_29685658[PMID]_27231142[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

26 annotations · validated 2019-04-29
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0011448Ankle clonus
HP:0008936Axial hypotonia
HP:0003487Babinski sign
HP:0002067Bradykinesia
HP:0002483Bulbar signs
HP:0001272Cerebellar atrophy
HP:0002059Cerebral atrophy
HP:0002376Developmental regression
HP:0100660Dyskinesia
HP:0001332Dystonia
HP:0001263Global developmental delay
HP:0030890Hyperintensity of cerebral white matter on MRI
HP:0032097Hypermanganesemia
HP:0001347Hyperreflexia
HP:0000338Hypomimic face
HP:0001249Intellectual disability
HP:0002505Loss of ambulation
HP:0002828Multiple joint contractures
HP:0012048Oromandibular dystonia
HP:0001300Parkinsonism
HP:0002465Poor speech
HP:0000253Progressive microcephaly
HP:0012407Scissor gait
HP:0002650Scoliosis
HP:0001257Spasticity
HP:0001337Tremor

Annotation source: 29382362[PMID]_29685658[PMID]_27231142[PMID]

7

Sources for this card